Functionalization of Human Serum Albumin by Tyrosine Click

Human serum albumin (HSA) is a promising drug delivery carrier. Although covalent modification of Cys34 is a well-established method, it is desirable to develop a novel covalent modification method that targets residues other than cysteine to introduce multiple functions into a single HSA molecule....

Full description

Bibliographic Details
Main Authors: Satsuki Obara, Keita Nakane, Chizu Fujimura, Shusuke Tomoshige, Minoru Ishikawa, Shinichi Sato
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/16/8676
_version_ 1797523572132937728
author Satsuki Obara
Keita Nakane
Chizu Fujimura
Shusuke Tomoshige
Minoru Ishikawa
Shinichi Sato
author_facet Satsuki Obara
Keita Nakane
Chizu Fujimura
Shusuke Tomoshige
Minoru Ishikawa
Shinichi Sato
author_sort Satsuki Obara
collection DOAJ
description Human serum albumin (HSA) is a promising drug delivery carrier. Although covalent modification of Cys34 is a well-established method, it is desirable to develop a novel covalent modification method that targets residues other than cysteine to introduce multiple functions into a single HSA molecule. We developed a tyrosine-selective modification of HSA. Three tyrosine selective modification methods, hemin-catalyzed, horseradish peroxidase (HRP)-catalyzed, and laccase-catalyzed reactions were performed, and the modification efficiencies and modification sites of the modified HSAs obtained by these methods were evaluated and compared. We found that the laccase-catalyzed method could efficiently modify the tyrosine residue of HSA under mild reaction conditions without inducing oxidative side reactions. An average of 2.2 molecules of functional groups could be introduced to a single molecule of HSA by the laccase method. Binding site analysis using mass spectrometry suggested Y84, Y138, and Y401 as the main modification sites. Furthermore, we evaluated binding to ibuprofen and found that, unlike the conventional lysine residue modification, the inhibition of drug binding was minimal. These results suggest that tyrosine-residue selective chemical modification is a promising method for covalent drug attachment to HSA.
first_indexed 2024-03-10T08:44:52Z
format Article
id doaj.art-7e7be93f13bf4900a44bd979debe57a0
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T08:44:52Z
publishDate 2021-08-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-7e7be93f13bf4900a44bd979debe57a02023-11-22T07:58:47ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-08-012216867610.3390/ijms22168676Functionalization of Human Serum Albumin by Tyrosine ClickSatsuki Obara0Keita Nakane1Chizu Fujimura2Shusuke Tomoshige3Minoru Ishikawa4Shinichi Sato5Graduate School of Life Sciences, Tohoku University, 2-1-1 Katahira, Aoba-ku, Sendai 980-8577, JapanGraduate School of Life Sciences, Tohoku University, 2-1-1 Katahira, Aoba-ku, Sendai 980-8577, JapanFrontier Research Institute for Interdisciplinary Sciences, Tohoku University, 2-1-1 Katahira, Aoba-ku, Sendai 980-8577, JapanGraduate School of Life Sciences, Tohoku University, 2-1-1 Katahira, Aoba-ku, Sendai 980-8577, JapanGraduate School of Life Sciences, Tohoku University, 2-1-1 Katahira, Aoba-ku, Sendai 980-8577, JapanGraduate School of Life Sciences, Tohoku University, 2-1-1 Katahira, Aoba-ku, Sendai 980-8577, JapanHuman serum albumin (HSA) is a promising drug delivery carrier. Although covalent modification of Cys34 is a well-established method, it is desirable to develop a novel covalent modification method that targets residues other than cysteine to introduce multiple functions into a single HSA molecule. We developed a tyrosine-selective modification of HSA. Three tyrosine selective modification methods, hemin-catalyzed, horseradish peroxidase (HRP)-catalyzed, and laccase-catalyzed reactions were performed, and the modification efficiencies and modification sites of the modified HSAs obtained by these methods were evaluated and compared. We found that the laccase-catalyzed method could efficiently modify the tyrosine residue of HSA under mild reaction conditions without inducing oxidative side reactions. An average of 2.2 molecules of functional groups could be introduced to a single molecule of HSA by the laccase method. Binding site analysis using mass spectrometry suggested Y84, Y138, and Y401 as the main modification sites. Furthermore, we evaluated binding to ibuprofen and found that, unlike the conventional lysine residue modification, the inhibition of drug binding was minimal. These results suggest that tyrosine-residue selective chemical modification is a promising method for covalent drug attachment to HSA.https://www.mdpi.com/1422-0067/22/16/8676tyrosine clickhuman serum albumindrug bindinglaccasemodification site
spellingShingle Satsuki Obara
Keita Nakane
Chizu Fujimura
Shusuke Tomoshige
Minoru Ishikawa
Shinichi Sato
Functionalization of Human Serum Albumin by Tyrosine Click
International Journal of Molecular Sciences
tyrosine click
human serum albumin
drug binding
laccase
modification site
title Functionalization of Human Serum Albumin by Tyrosine Click
title_full Functionalization of Human Serum Albumin by Tyrosine Click
title_fullStr Functionalization of Human Serum Albumin by Tyrosine Click
title_full_unstemmed Functionalization of Human Serum Albumin by Tyrosine Click
title_short Functionalization of Human Serum Albumin by Tyrosine Click
title_sort functionalization of human serum albumin by tyrosine click
topic tyrosine click
human serum albumin
drug binding
laccase
modification site
url https://www.mdpi.com/1422-0067/22/16/8676
work_keys_str_mv AT satsukiobara functionalizationofhumanserumalbuminbytyrosineclick
AT keitanakane functionalizationofhumanserumalbuminbytyrosineclick
AT chizufujimura functionalizationofhumanserumalbuminbytyrosineclick
AT shusuketomoshige functionalizationofhumanserumalbuminbytyrosineclick
AT minoruishikawa functionalizationofhumanserumalbuminbytyrosineclick
AT shinichisato functionalizationofhumanserumalbuminbytyrosineclick